Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Top Stories > AMPAC Fine Chemicals To Be Acquired By SK Holdings

AMPAC Fine Chemicals To Be Acquired By SK Holdings

Published by Gbaf News

Posted on July 17, 2018

3 min read

Last updated: January 21, 2026

Shisha tobacco culture growth and global impact on cafes and social gatherings - Global Banking & Finance Review — An illustration depicting the rise of shisha tobacco culture and its influence on social gatherings, cafes, and restaurants, highlighting its global market growth as discussed in the FMI study.

AMPAC Fine Chemicals (“AFC”), a leading US-based Contract Development and Manufacturing Organization (“CDMO”), today announced its sale to SK Holdings (“SK”), an investment holding company of SK Group (South Korea). This acquisition is the largest M&A transaction announced in the Korean pharmaceutical industry.

Since February 2014, AFC has been owned by H.I.G. Capital (“H.I.G.”), a global private equity firm. Under H.I.G.’s ownership, AFC expanded the manufacturing footprint at Rancho Cordova, CA facility, started AMPAC Analytical, acquired a state-of-the art plant in Petersburg, VA, substantially enhanced its product pipeline, and delivered industry-leading growth every year since acquisition.

SK is purchasing AFC due to its unique capabilities, world class facilities, excellent reputation, outstanding people and great growth potential. AFC is SK’s sole CDMO operation in the US and will play a crucial part in SK’s development as a global leader in pharmaceuticals manufacturing.

“Pharmaceuticals is one of SK Holdings’ key pillars of growth and the acquisition of AFC is an important step towards becoming a global player in the market,” said Donghyun Jang, President and Chief Executive Officer of SK Holdings. Mr. Jang added, “AFC’s development and manufacturing capabilities and outstanding regulatory track record are an excellent complement to SK.”

Aslam Malik, Chief Executive Officer of AFC, added, “We are excited to join SK Holdings. SK and AFC are highly complementary and with SK’s strong presence in Europe and Asia, we will be able to provide our customers a much broader portfolio of offerings including a global supply chain. Together we will achieve SK’s goal of becoming a global, top-tier CDMO.”

AMPAC Fine Chemicals (“AFC”), a leading US-based Contract Development and Manufacturing Organization (“CDMO”), today announced its sale to SK Holdings (“SK”), an investment holding company of SK Group (South Korea). This acquisition is the largest M&A transaction announced in the Korean pharmaceutical industry.

Since February 2014, AFC has been owned by H.I.G. Capital (“H.I.G.”), a global private equity firm. Under H.I.G.’s ownership, AFC expanded the manufacturing footprint at Rancho Cordova, CA facility, started AMPAC Analytical, acquired a state-of-the art plant in Petersburg, VA, substantially enhanced its product pipeline, and delivered industry-leading growth every year since acquisition.

SK is purchasing AFC due to its unique capabilities, world class facilities, excellent reputation, outstanding people and great growth potential. AFC is SK’s sole CDMO operation in the US and will play a crucial part in SK’s development as a global leader in pharmaceuticals manufacturing.

“Pharmaceuticals is one of SK Holdings’ key pillars of growth and the acquisition of AFC is an important step towards becoming a global player in the market,” said Donghyun Jang, President and Chief Executive Officer of SK Holdings. Mr. Jang added, “AFC’s development and manufacturing capabilities and outstanding regulatory track record are an excellent complement to SK.”

Aslam Malik, Chief Executive Officer of AFC, added, “We are excited to join SK Holdings. SK and AFC are highly complementary and with SK’s strong presence in Europe and Asia, we will be able to provide our customers a much broader portfolio of offerings including a global supply chain. Together we will achieve SK’s goal of becoming a global, top-tier CDMO.”